Guidepoint Qsight offers institutional investors exclusive, near-real-time quantitative insights into the MedTech market. We deliver highly accurate and timely revenue projections and performance tracking from the industry’s largest datasets.
Empower Your Healthcare Investment Decisions with Our Advanced Data Analytics Suite
Built specifically for Investors and based on the latest and most robust healthcare data, Qsight Alpha consistently outperforms consensus, offering action-oriented insights into the performance and anticipated revenues of companies in the MedTech and Aesthetics sectors.
Explore Our Product Offerings Designed Specifically for Healthcare Investors
AlphaInstitutional investors gain unparalleled visibility into the performance and anticipated revenues of MedTech companies via proprietary, validated models built from transactional healthcare data.
FAQs: How We Can Help Healthcare Investors
Guidepoint Qsight provides investors with detailed data and insights, combining real-time transaction data and market projections to help assess company performances and enhance visibility in the MedTech sector.
Qsight ensures accurate and timely market projections by analyzing transactional data from U.S. healthcare facilities, offering precise insights into market dynamics to inform investment decisions.
Qsight tracks product-level performance at a variety of healthcare facility types, offering investors critical insights into product success, market adoption rates, and competitive positioning across Medical Device, HME/DME, and Aesthetics sectors.
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
Lightning Strikes the Peripheral Thrombectomy Market: Examining the Rise of Penumbra and the Impact of Innovative Devices
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Rapid Ascend: Axonics Gains Ground in the SNM Market Amid F15 Launch and Next-Gen R20 System Arrival
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.
Medical Aesthetics Industry Faces Economic Uncertainty: Putting the “Lipstick Effect” to the Test
As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.
TAVR: A Turbulent Journey Through Pandemic Recovery
With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.